EcoDrugPlus

Glutamate Receptor Ionotropic, Kainate 2

Ensembl ID : ENSMAMG00000006597
Gene Symbol: LOC113137029
2 Cross references
253 Possible Orthologues:

Glutamate Receptor Ionotropic, Kainate 5-Like

Ensembl ID : ENSMAMG00000021093
Gene Symbol: LOC113126094
2 Cross references
229 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1a

Ensembl ID : ENSMAMG00000012778
Gene Symbol: GRIA1A
3 Cross references
251 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1b

Ensembl ID : ENSMAMG00000001812
Gene Symbol: GRIA1B
2 Cross references
249 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSMAMG00000002020
Gene Symbol: GRIA4B
2 Cross references
249 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSMAMG00000002912
Gene Symbol: GRIN1A
3 Cross references
205 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1b

Ensembl ID : ENSMAMG00000019104
Gene Symbol: GRIN1B
2 Cross references
178 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2a, A

Ensembl ID : ENSMAMG00000003746
Gene Symbol: GRIN2AA
2 Cross references
228 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2a, B

Ensembl ID : ENSMAMG00000007991
Gene Symbol: GRIN2AB
2 Cross references
98 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2ca

Ensembl ID : ENSMAMG00000019798
Gene Symbol: GRIN2CA
2 Cross references
115 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2d, A

Ensembl ID : ENSMAMG00000019291
Gene Symbol: GRIN2DA
2 Cross references
214 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl-D-Aspartate 3a

Ensembl ID : ENSMAMG00000005687
Gene Symbol: GRIN3A
2 Cross references
245 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).